A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy
暂无分享,去创建一个
M. Sakaguchi | Masami Watanabe | I. Date | H. Kumon | Y. Nasu | Y. Tomita | T. Ichikawa | Y. Otani | K. Kurozumi | Y. Shimazu | Joji Ishida | T. Oka | Toshihiko Shimizu | Yoshihiro Otani
[1] Norma E. Conner,et al. Advances and Challenges , 2016, The American journal of hospice & palliative care.
[2] Masami Watanabe,et al. Synergistic anti‐pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf‐3 protein and peripheral blood mononuclear cells , 2015, Journal of gastroenterology and hepatology.
[3] Masami Watanabe,et al. Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy , 2015, Clinical and translational science.
[4] I. Date,et al. [Molecular-Targeted Drug Therapy for Glioma Angiogenesis and Invasion]. , 2015, No shinkei geka. Neurological surgery.
[5] S. Kanazawa,et al. Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy , 2015, Clinical Medicine Insights. Oncology.
[6] K. Fujii,et al. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma , 2014, Gene Therapy.
[7] M. Sakaguchi,et al. A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector , 2013, Oncology reports.
[8] Masami Watanabe,et al. Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review) , 2013, Oncology letters.
[9] I. Date,et al. Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme , 2013, Neurologia medico-chirurgica.
[10] E. Chiocca,et al. The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus , 2013, Cancer Gene Therapy.
[11] H. Yamada,et al. A novel gene expression system for detecting viable bladder cancer cells. , 2012, International journal of oncology.
[12] K. Ochiai,et al. Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging. , 2011, Oncology reports.
[13] I. Date,et al. Angiogenesis and invasion in glioma , 2011, Brain Tumor Pathology.
[14] Y. Naomoto,et al. Adenovirus-mediated cancer gene therapy and virotherapy (Review). , 2009, International journal of molecular medicine.
[15] S. Kyo,et al. A simple biological imaging system for detecting viable human circulating tumor cells. , 2009, The Journal of clinical investigation.
[16] M. Sakaguchi,et al. Down‐regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene‐therapeutic overexpression of REIC/Dkk‐3 , 2009, International journal of cancer.
[17] M. Sakaguchi,et al. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. , 2009, International journal of oncology.
[18] M. Sakaguchi,et al. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. , 2008, Cancer research.
[19] H. Mure,et al. REIC/Dkk-3 induces cell death in human malignant glioma. , 2008, Neuro-oncology.
[20] R. Weissleder,et al. Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy. , 2007, Journal of the National Cancer Institute.
[21] M. Gilbert,et al. Molecularly targeted therapies for malignant gliomas: advances and challenges , 2007, Expert review of anticancer therapy.
[22] M. Sakaguchi,et al. REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. , 2007, International journal of molecular medicine.
[23] Keerang Park,et al. Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells. , 2006, Oncology reports.
[24] M. Sakaguchi,et al. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. , 2005, Cancer research.
[25] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[26] Joon-Seok Song. Enhanced Expression of Apoptin by the Myc–Max Binding Motif and SV40 Enhancer for SCLC Gene Therapy , 2005, Bioscience, biotechnology, and biochemistry.
[27] Y. Wong,et al. Id-1 expression and cell survival , 2004, Apoptosis.
[28] D. Dean,et al. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature , 2003, Gene Therapy.
[29] T. Mayumi,et al. Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[30] M. Sakaguchi,et al. Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. , 2001, Biochemical and Biophysical Research Communications - BBRC.
[31] Marty W. Mayo,et al. WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.
[32] M. Sakaguchi,et al. A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. , 2000, Biochemical and biophysical research communications.
[33] T. Ichikawa,et al. Integrin inhibitor suppresses bevacizumab-induced glioma invasion , 2014 .
[34] I. Date,et al. Cilengitide treatment for malignant glioma: current status and future direction. , 2012, Neurologia medico-chirurgica.